Key regions: Australia, Brazil, United Kingdom, Europe, Canada
The Other Vaccines market in Armenia has been experiencing steady growth in recent years.
Customer preferences: Armenians are becoming increasingly aware of the importance of vaccines in preventing diseases. This is leading to a rise in demand for Other Vaccines, which are used to protect against illnesses such as shingles, pneumonia, and meningitis. Additionally, there is a growing trend towards preventative healthcare, with many Armenians opting to take vaccines as a preventative measure rather than waiting until they become ill.
Trends in the market: One of the key trends in the Other Vaccines market in Armenia is the increasing availability of vaccines. As the country's healthcare infrastructure continues to develop, more vaccines are becoming available to the general public. This is leading to greater awareness of the benefits of vaccination and driving demand for Other Vaccines.Another trend in the market is the growing popularity of combination vaccines. These vaccines protect against multiple diseases at once, making them more convenient for patients and reducing the number of vaccinations required. As a result, combination vaccines are becoming increasingly popular in Armenia.
Local special circumstances: Armenia has a relatively high incidence of vaccine-preventable diseases, which is driving demand for Other Vaccines. Additionally, the country has a high rate of emigration, with many Armenians living abroad in countries with more developed healthcare systems. This has led to a greater awareness of the importance of preventative healthcare, including vaccination.
Underlying macroeconomic factors: Armenia's healthcare system is undergoing significant modernization and investment, which is driving growth in the Other Vaccines market. Additionally, the country's economy is growing, leading to increased disposable income and greater demand for healthcare services. These factors are expected to continue to support growth in the Other Vaccines market in Armenia in the coming years.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
